Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Psychiatry Reports
Published in: Current Psychiatry Reports 3/2016

01-03-2016 | Anxiety Disorders (A Pelissolo, Section Editor)

New Developments in Cognitive-Behavioral Therapy for Social Anxiety Disorder

Author: Ulrich Stangier

Published in: Current Psychiatry Reports | Issue 3/2016

Login to get access

Abstract

Social anxiety disorder (SAD) is a highly prevalent and chronic disorder that causes considerable psychosocial impairment. This article reviews recent changes in the definition of SAD in DSM-5 and summarizes the current evidence for effective cognitive-behavioral treatments in adults, children, and adolescents. Current data suggests that cognitive-behavioral therapy (CBT) is efficacious in the treatment of this condition. Among different CBT approaches, individual cognitive therapy may be associated with the largest effect sizes. In this review, interventions targeting dysfunctional cognitive processes that contribute to the effective treatment of SAD are discussed. Some recent findings from neuroimaging research and studies on the augmentation of CBT using neuroenhancers indicate that changes in emotion regulation as well as fear extinction are important psychological mediators of positive outcome. Furthermore, internet-delivered CBT is a promising field of technological innovation that may improve access to effective treatments. Despite the availability of effective treatments, treatment-resistant SAD remains a common problem in clinical practice that requires more research efforts. Finally, potential areas for further development of CBT as well as its dissemination in health care are summarized.
Literature
1.
American Psychiatric Association. Diagnostic and statistical manual for mental disorders, 5th edition (DSM-5). Arlington, VA: American Psychiatric Publishing; 2013.
2.
Ruscio AM, Brown TA, Chiu WT, Sareen JJ, Stein MB, Kessler RC. Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication. Psychol Med. 2008;38(1):15–28.PubMedCentralCrossRefPubMed
3.
Heimberg RG, Hofmann SG, Liebowitz MR, Schneier FR, Smits JA, Stein MB, et al. Social anxiety disorder in DSM-5. Depress Anxiety. 2014;31(6):472–9.
4.
Acarturk C, Cuijpers P, van Straten A, de Graaf R. Psychological treatment of social anxiety disorder: a meta-analysis. Psychol Med. 2009;39(2):241–54.CrossRefPubMed
5.
6.••
Mayo-Wilson E, Dias S, Mavranezouli I, Kew K, Clark D, Ades AE, et al. Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2014;1(5):368–76. This network meta-analysis is the latest and most comprehensive meta-analysis which summarizes the evidence that individual CBT is the most effective treatment for social anxiety disorder.
7.
Clark DM, Ehlers A, McManus F, Hackmann A, Fennell M, Campbell H, et al. Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial. J Consult Clin Psychol. 2003;71(6):1058–67.
8.•
Clark DM, Ehlers A, Hackmann A, McManus F, Fennell M, Grey N, et al. Cognitive therapy versus exposure and applied relaxation in social phobia: a randomized controlled trial. J Consult Clin Psychol. 2006;74(3):568–78. This randomized controlled trial demonstrates that cognitive therapy based on the Clark and Wells model is significantly superior to exposure and a highly effective treatment for SAD.
9.
Clark DM, Wells A. A cognitive model of social phobia. In: Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, editors. Social phobia: diagnosis, assessment and treatment. New York: Guilford; 1995. p. 69–93.
10.
Pilling S, Mayo-Wilson E, Mavranezouli I, Kew K, Taylor C, Clark DM, et al. Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidance. BMJ. 2013;346:f2541
11.
In-Albon T, Schneider S. Psychotherapy of childhood anxiety disorders: a meta-analysis. Psychother Psychosom. 2007;76(1):15–24. CrossRefPubMed
12.
13.
Beidel DC, Turner SM, Sallee FR, Ammerman RT, Crosby LA, Pathak S. SET-C versus fluoxetine in the treatment of childhood social phobia. J Am Acad Child Adolesc Psychiatry. 2007;46(12):1622–32.CrossRefPubMed
14.
Melfsen S, Kühnemund M, Schwieger J, Warnke A, Stadler C, Poustka F, et al. Cognitive behavioral therapy of socially phobic children focusing on cognition: a randomised wait-list control study. Child Adolesc Psychiatry Ment Health. 2011;5(1):5.
15.
Hofmann SG. Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders. Clin Psychol Rev. 2008;28(2):199–210.PubMedCentralCrossRefPubMed
16.
Rapee RM, Heimberg RG. A cognitive-behavioral model of anxiety in social phobia. Behav Res Ther. 1997;35(8):741–56.CrossRefPubMed
17.
McManus F, Clark DM, Grey N, Wild J, Hirsch C, Fennell M, et al. A demonstration of the efficacy of two of the components of cognitive therapy for social phobia. J Anxiety Disord. 2009;23(4):496–503.
18.
Schreiber F, Heimlich C, Schweitzer C, Stangier U. Cognitive therapy for social anxiety disorder: the impact of the “self-focused attention and safety behaviours experiment” on the course of treatment. Behav Cogn Psychother. 2015;43:158–66.CrossRefPubMed
19.
Wells A, White J, Carter K. Attention training: effects on anxiety and beliefs in panic and social phobia. Clin Psychol Psychother. 1997;4:226–32.CrossRef
20.
Donald J, Abbott MJ, Smith E. Comparison of attention training and cognitive therapy in the treatment of social phobia: a preliminary investigation. Behav Cogn Psychother. 2014;42(1):74–91.CrossRefPubMed
21.
Kuckertz JM, Amir N. Attention bias modification for anxiety and phobias: current status and future directions. Curr Psychiatry Rep. 2015;17(2):1–8.CrossRef
22.
Rodebaugh TL, Heimberg RG, Schultz LT, Blackmore M. The moderated effects of video feedback for social anxiety disorder. J Anxiety Disord. 2010;24(7):663–71.PubMedCentralCrossRefPubMed
23.
24.
Lee SW, Kwon JH. The efficacy of imagery rescripting (IR) for social phobia: a randomized controlled trial. J Behav Ther Exp Psychiatry. 2013;44(4):351–60.CrossRefPubMed
25.
McMillan D, Lee R. A systematic review of behavioral experiments vs. exposure alone in the treatment of anxiety disorders: a case of exposure while wearing the emperor’s new clothes? Clin Psychol Rev. 2010;30(5):467–78.CrossRefPubMed
26.
27.
Härtling S, Klotsche J, Heinrich A, Hoyer J. Cognitive therapy and task concentration training applied as intensified group therapies for social anxiety disorder with fear of blushing—a randomized controlled trial. Clin Psychol Psychother. 2015 Oct 9. [doi: 10.1002/cpp.1975]
28.
29.
Leichsenring F, Salzer S, Beutel ME, Herpertz S, Hiller W, Hoyer J, et al. Psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: a multicenter randomized controlled trial. Am J Psychiatry. 2013;170(7):759–67.
30.
Stangier U, Von Consbruch K, Höfling V, Lücke P, Lin J, Leibing E, et al. Effective components of cognitive therapy for social anxiety disorder. Paper presented on the 44th Congress of the European Association for Behavioural & Cognitive Therapies. The Netherlands: The Hague; 10–13 Sept. 2014.
31.
Stangier U, Heidenreich T, Peitz M, Lauterbach W, Clark DM. Cognitive therapy for social phobia: individual versus group treatment. Behav Res Ther. 2003;41(9):991–1007.CrossRefPubMed
32.
Mörtberg E, Clark DM, Sundin O, Aberg WA. Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: a randomized controlled trial. Acta Psychiatr Scand. 2007;115(2):142–54.CrossRefPubMed
33.
Stangier U, Schramm E, Heidenreich T, Berger M, Clark DM. Cognitive therapy versus interpersonal psychotherapy in social phobia: a randomized controlled trial. Arch Gen Psychiatry. 2011;68(7):692–700.CrossRefPubMed
34.
Robinson OJ, Krimsky M, Lieberman L, Allen P, Vytal K, Grillon C. Towards a mechanistic understanding of pathological anxiety: the dorsal medial prefrontal-amygdala ‘aversive amplification’ circuit in unmedicated generalized and social anxiety disorders. Lancet Psychiatry. 2014;1(4):294–302.PubMedCentralCrossRefPubMed
35.
35 Gentili C, Cristea IA, Angstadt M, Klumpp H, Tozzi L, Phan KL, Pietrini P. Beyond emotions: A meta-analysis of neural response within face processing system in social anxiety. Exp Biol Med. 2015; epub ahead of print. [PubMed: 26341469]
36.•
Goldin PR, Ziv M, Jazaieri H, Weeks J, Heimberg RG, Gross JJ. Impact of cognitive-behavioral therapy for social anxiety disorder on the neural bases of emotional reactivity to and regulation of social evaluation. Behav Res Ther. 2014; 62:97–106. This study finds evidence for the neurobiological basis of changes in maladaptive emotion regulations strategies as a predictor for treatment response in CBT for SAD.
37.
Klumpp H, Keutmann MK, Fitzgerald DA, Shankman SA, Phan KL. Resting state amygdala-prefrontal connectivity predicts symptom change after cognitive behavioral therapy in generalized social anxiety disorder. Biol Mood Anxiety Disord. 2014;4(1):14.PubMedCentralCrossRefPubMed
38.
38 Whitfield-Gabrieli S, Ghosh SS, Nieto-Castanon A, Saygin Z, Doehrmann O, Chai XJ, Reynolds GO, Hofmann SG, Pollack MH, Gabrieli JD. Brain connectomics predict response to treatment in social anxiety disorder. Mol Psychiatry. 2015; epub ahead of print. [PubMed: 26260493]
39.
40.
41.
Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, et al. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006;63(3):298–304.
42.
Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinol. 2009;34(6):917–23.CrossRef
43.
Rodebaugh TL, Levinson CA, Lenze EJ. A high-throughput clinical assay for testing drug facilitation of exposure therapy. Depress Anxiety. 2013;30(7):631–7.PubMedCentralCrossRefPubMed
44.•
Hofmann SG, Smits JA, Rosenfield D, Simon N, Otto MW, Meuret AE, Marques L, Fang A, Tart C, Pollack MH. D-Cycloserine as an augmentation strategy of cognitive behavioral therapy for social anxiety disorder. Am J Psychiatry. 2013; 170(7): 751–758. This randomized controlled trial is the largest study on neuroenhancement of exposure treatment using D-cycloserine. Although there was no significant benefit by augmentation with DCS, it accelerated the effects of exposure and significantly improved the effects of successful exposure sessions.
45.
Smits JA, Rosenfield D, Davis ML, Julian K, Handelsman PR, Otto MW, et al. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial. Biol Psychiatry. 2014;75(11):840–6.
46.
Hofmann SG, Fang A, Brager DN. Effect of intranasal oxytocin administration on psychiatric symptoms: a meta-analysis of placebo-controlled studies. Psychiatry Res. 2015;228(3):708–14.CrossRefPubMed
47.
Zbozinek TD, Holmes EA, Craske MG. The effect of positive mood induction on reducing reinstatement fear: relevance for long term outcomes of exposure therapy. Behav Res Ther. 2015;71:65–75.PubMedCentralCrossRefPubMed
48.
48 Barry TJ, Sewart AR, Arch JJ, Craske MG. Deficits in disengaging attention from threat predict improved response to cognitive behavioral therapy for anxiety. Depress Anxiety. 2015; epub ahead of print. [PubMed: 26372291]
49.
Andersson G. Using the Internet to provide cognitive behaviour therapy. Behav Res Ther. 2009;47(3):175–80.CrossRefPubMed
50.•
Arnberg FK, Linton SJ, Hultcrantz M, Heintz E, Jonsson U. Internet-delivered psychological treatments for mood and anxiety disorders: a systematic review of their efficacy, safety, and cost-effectiveness. PLoS One. 2014; 9(5):e98118. [PubMed: 24844847] This latest meta-analysis demonstrates that internet-delivered CBT is effective in SAD and depression, but that there is not sufficient evidence for its equivalence with face-to-face treatment for social anxiety disorder.
51.
Andersson G, Cuijpers P, Carlbring P, Riper H, Hedman E. Guided Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: a systematic review and meta-analysis. World Psychiatry. 2014;13(3):288–95.PubMedCentralCrossRefPubMed
52.
Stott R, Wild J, Grey N, Liness S, Warnock-Parkes E, Commins S, et al. Internet-delivered cognitive therapy for social anxiety disorder: a development pilot series. Behav Cogn Psychother. 2013;41(4):383–97.
53.
Palmqvist B, Carlbring P, Andersson G. Internet-delivered treatments with or without therapist input: does the therapist factor have implications for efficacy and cost? Expert Rev Pharmacoecon Outcomes Res. 2007;7(3):291–7.CrossRefPubMed
54.
Weisberg RB, Dyck I, Culpepper L, Keller MB. Psychiatric treatment in primary care patients with anxiety disorders: a comparison of care received from primary care providers and psychiatrists. Am J Psychiat. 2007;164(2):276–82.CrossRefPubMed
55.
Menezes GB, Fontenelle LF, Mululo S, Versiani M. Treatment-resistant anxiety disorders: social phobia, generalized anxiety disorder and panic disorder. Rev Bras Psiquiatr. 2007;29(2):55–60.CrossRef
56.
Pollack MH, Van Ameringen M, Simon NM, et al. A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry. 2014;171(1):44–53.CrossRefPubMed
57.
Craske MG, Golinelli D, Stein MB, Roy-Byrne P, Bystritsky A, Sherbourne C. Does the addition of cognitive behavioral therapy improve panic disorder treatment outcome relative to medication alone in the primary-care setting? Psychol Med. 2005;35(11):1645–54.CrossRefPubMed
58.
Heldt E, Gus Manfro G, Kipper L, Blaya C, Isolan L, Otto MW. One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission. Behav Res Ther. 2006;44(5):657–65.CrossRefPubMed
59.
Otto MW, Hong JJ, Safren SA. Benzodiazepine discontinuation difficulties in panic disorder: conceptual model and outcome for cognitive-behavior therapy. Curr Pharm Des. 2002;8(1):75–80.CrossRefPubMed
60.
Schmidt NB, Wollaway-Bickel K, Trakowski JH, Santiago HT, Vasey M. Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder. Behav Res Ther. 2002;40(1):67–73.CrossRefPubMed
61.
Otto MW, Hinton D, Korbly NB, Chea A, Ba P, Gershuny BS, et al. Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone. Behav Res Ther. 2003;41(11):1271–6.
62.
Vervliet B, Craske MG, Hermans D. Fear extinction and relapse: state of the art. Annu Rev Clin Psychol. 2013;9:215–48.CrossRefPubMed
63.
Mörtberg E, Hoffart A, Boecking B, Clark DM. Shifting the focus of one’s attention mediates improvement in cognitive therapy for social anxiety disorder. Behav Cogn Psychother. 2015;43(1):63–73.CrossRefPubMed
64.•
Jazaieri H, Morrison AS, Goldin PR, Gross JJ. The role of emotion and emotion regulation in social anxiety disorder. Curr Psychiatry Rep. 2015; 17(1):531. This article reviews the evidence for emotional dysregulation in social anxiety disorder and proposes the use of interventions to improve adaptive emotion regulations strategies in the treatment of SAD.
65.
66.
Koszycki D, Benger M, Shlik J, Bradwejn J. Randomized trial of a meditation-based stress reduction program and cognitive behavior therapy in generalized social anxiety disorder. Behav Res Ther. 2007;45(10):2518–26.CrossRefPubMed
67.
68.
Jazaieri H, Goldin PR, Werner K, Ziv M, Gross JJ. A randomized trial of MBSR versus aerobic exercise for social anxiety disorder. J Clin Psychol. 2012;68(7):715–31.PubMedCentralCrossRefPubMed
69.
Craske MG, Niles AN, Burklund LJ, Wolitzky-Taylor KB, Vilardaga JC, Arch JJ, et al. Randomized controlled trial of cognitive behavioral therapy and acceptance and commitment therapy for social phobia: outcomes and moderators. J Consult Clin Psychol. 2014;82(6):1034–48.
70.
Shafran R, Clark DM, Fairburn CG, Arntz A, Barlow DH, Ehlers A, et al. Mind the gap: improving the dissemination of CBT. Behav Res Ther. 2009;47(11):902–9.
71.
72.
Ginzburg DM, Bohn C, Höfling V, Weck F, Clark DM, Stangier U. Treatment specific competence predicts outcome in cognitive therapy for social anxiety disorder. Behav Res Ther. 2012;50(12):747–52.PubMedCentralCrossRefPubMed
73.
Stein MB, Sherbourne CD, Craske MG, Means-Christensen A, Bystritsky A, Katon W, et al. Quality of care for primary care patients with anxiety disorders. Am J Psychiatry. 2004;161(12):2230–7.
74.
Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005;15:357–76.CrossRefPubMed
Metadata
Title
New Developments in Cognitive-Behavioral Therapy for Social Anxiety Disorder
Author
Ulrich Stangier
Publication date
01-03-2016
Publisher
Springer US
Published in
Current Psychiatry Reports / Issue 3/2016
Print ISSN: 1523-3812
Electronic ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-016-0667-4

Other articles of this Issue 3/2016

Current Psychiatry Reports 3/2016 Go to the issue

Personality Disorders (C Schmahl, Section Editor)

Avoidant Personality Disorder: a Current Review

Military Mental Health (CH Warner, Section Editor)

The Importance of Military Cultural Competence

Psychiatry in Primary Care (BN Gaynes, Section Editor)

What Should Primary Care Providers Know About the Changes in DSM-5?

Women’s Mental Health (CN Epperson, Section Editor)

Sexual Function Across Aging

Psychiatric Diagnosis (MB First, Section Editor)

The Prevalence and Diagnostic Validity of Short-Duration Hypomanic Episodes and Major Depressive Episodes

Complex Medical-Psychiatric Issues (MB Riba, Section Editor)

Depression During Pregnancy and Postpartum